Mast Cell Inflammatory Mediators
Mast cells release three major categories of inflammatory mediators: preformed granule mediators (histamine, tryptase, chymase, heparin, and other proteases), newly synthesized lipid mediators (prostaglandin D2 and leukotriene C4), and cytokines/chemokines (TNF-α, IL-6, IL-8, IL-1β, and MCP-1).
Preformed Mediators (Released Immediately Upon Degranulation)
The most clinically significant preformed mediators stored in mast cell secretory granules include 1:
- Histamine - synthesized from L-histidine and rapidly metabolized (half-life 1-2 minutes) to N-methylhistamine
- Tryptase (α/β-tryptases) - the major protein component of secretory granules, used as a biomarker for mast cell activation
- Chymase, carboxypeptidase A3, and cathepsin G - found in a subset of mast cells (tryptase and chymase double-positive)
- Heparan and chondroitin sulfate proteoglycans - predominantly found in mast cells
- Acid hydrolases - present in all mast cells
These mediators are released within minutes of mast cell activation and are responsible for immediate symptoms like urticaria, bronchoconstriction, and hypotension 2.
Newly Synthesized Lipid Mediators (Generated De Novo)
Upon activation, mast cells synthesize 1:
- Prostaglandin D2 (PGD2) - can be measured via its metabolite 11β-PGF2α in urine
- Leukotriene C4 (LTC4) - metabolized to LTD4 and LTE4, which can be measured in urine
These eicosanoids are produced through COX and 5-lipoxygenase pathways respectively and contribute to sustained inflammatory responses 3.
Cytokines and Chemokines (Delayed Release)
Mast cells produce multiple pro-inflammatory cytokines and chemokines 1, 4:
- TNF-α - key pro-inflammatory cytokine
- IL-6 - associated with delayed deterioration in anaphylaxis
- IL-8 - chemokine for neutrophil recruitment
- IL-1β - pro-inflammatory cytokine
- IL-10 - can have anti-inflammatory effects
- MCP-1 - monocyte chemoattractant
Clinical Significance
The release pattern matters clinically. Preformed mediators cause immediate symptoms (within minutes), while cytokines and chemokines contribute to biphasic reactions and chronic inflammation 5. In anaphylaxis, elevated levels of histamine, tryptase, IL-6, IL-10, and TNF-receptor 1 correlate with delayed deterioration occurring hours after initial presentation 5.
Diagnostic Utility
For diagnosing mast cell activation syndrome, measure serum tryptase during acute episodes (ideally within 1-4 hours of symptom onset) and compare to baseline, along with urine metabolites of histamine (N-methylhistamine), PGD2 (11β-PGF2α), and leukotrienes (LTE4) 1.
The mediators released depend on the activation stimulus and mast cell subtype, with differential secretion patterns occurring based on whether activation occurs through FcεRI, FcγRI/IIa, G protein-coupled receptors, or Toll-like receptors 1.